P56817 (BACE1_HUMAN) Homo sapiens (Human)

Beta-secretase 1 UniProtKBInterProSTRINGInteractive Modelling

501 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6); 3 identical sequences: Homo sapiens: A0A024R3D7; Pan troglodytes: A0A803KHP3, K7BR34

Available Structures

430 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE AND EXOSITE BINDING PEPTIDE INHIBITOR Heteromer
EDO;56-448
Assess
Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody Heteromer
57-447
Assess
VHS domain of human GGA1 complexed with C-terminal phosphopeptide from BACE Heteromer
Q9UJY5;
IOD;495-501
Assess
VHS domain of human GGA1 complexed with C-terminal peptide from BACE Heteromer
Q9UJY5;
495-501
Assess
Complex of GGA1-VHS domain and beta-secretase C-terminal phosphopeptide Heteromer
Q9UJY5;
495-501
Assess
Structure of BACE bound to SCH346572homo-2-merG00;53-447
Assess
Structure of BACE bound to SCH12472homo-2-merD8Y;53-447
Assess
Crystal Structure of Human Beta Secretase Complexed with inhibitorhomo-2-merQIN;56-446
Assess
Structure of BACE Bound to (S)-4-(3'-methoxy-[1,1'-biphenyl]-3-yl)-1,4-dimethyl-6-oxotetrahydropyri…homo-2-merH24;TLA;58-447
Assess
Structure of BACE Bound to SCH743641homo-2-merTLA;Z75;58-447
Assess
Structure of BACE bound to SCH708236homo-2-mer3TO;TLA;58-447
Assess
Structure of BACE Bound to SCH747123homo-2-merTLA;Z76;58-447
Assess
Structure of BACE Bound to SCH745132homo-2-merTLA;Z74;58-447
Assess
X-ray crystal structure of beta secretase complexed with compound 27homo-2-merIOD;C27;60-447
Assess
X-ray crystal structure of beta secretase complexed with compound 24homo-2-merIOD;H24;60-447
Assess
X-ray crystal structure of beta secretase complexed with compound 8chomo-2-merIOD;C8C;60-447
Assess
Crystal Structure of Human Beta Secretase Complexed with Spiropiperdine Iminohydantoin Inhibitorhomo-2-merSII;58-444
Assess
Crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with bms-681889 aka n~1~-but…homo-2-mer3HH;SO4;GOL;60-446
Assess
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with bms-655295 aka n~3~-((1…homo-2-mer3HF;IOD;GOL;60-446
Assess
Structure of BACE complexed to compound 3ahomo-2-mer3MR;62-446
Assess
BACE1 compound 28monomerB7E;37-445
Assess
Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhib…monomerNI;2X5;57-453
Assess
Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhib…monomerNI;2X4;57-453
Assess
Aminooxazoline inhibitor of BACE-1monomerNI;1WP;58-453
Assess
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 InhibitorsmonomerZN;1B8;58-453
Assess
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 InhibitorsmonomerZN;1B9;58-453
Assess
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) InhibitorsmonomerNI;1M7;58-453
Assess
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) InhibitorsmonomerNI;1M6;58-453
Assess
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomerZN;0ZA;58-453
Assess
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) InhibitorsmonomerNI;1M5;58-453
Assess
Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) InhibitorsmonomerNI;1M4;58-453
Assess
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 InhibitorsmonomerZN;1BF;58-453
Assess
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomerZN;1CH;58-453
Assess
SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitorsmonomerZN;842;58-453
Assess
Structure of BACE Bound to SCH589432monomerCS5;53-447
Assess
Crystal Structure of BACE with Compound 14gmonomer0UP;ZN;60-453
Assess
Crystal Structure of BACE with Compound 1monomer091;EDO;ZN;60-453
Assess
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomerNI;3J9;60-453
Assess
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomerNI;3UX;60-453
Assess
Crystal Structure of BACE with Compound 5monomer092;EDO;PEG;ZN;60-453
Assess
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomerNI;3UY;60-453
Assess
Discovery of 7-THP chromans: BACE1 inhibitors that reduce A-beta in the CNSmonomerNI;2EX;60-453
Assess
8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy…monomerNI;3UW;60-453
Assess
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomer1BB;ZN;60-453
Assess
Crystal Structure of BACE with Compound 12amonomer0UQ;ZN;EDO;60-453
Assess
Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 InhibitorsmonomerZN;1B7;60-453
Assess
Crystal Structure of BACE with Compound 8monomer09A;ZN;EDO;PEG;60-453
Assess
Crystal Structure of BACE with Compound 14monomer09F;EDO;PEG;ZN;60-453
Assess
Crystal Structure of BACE with Compound 12monomer09D;EDO;PEG;ZN;60-453
Assess
Crystal structure of human BACE-1 bound to Compound 24Bmonomer3VO;60-453
Assess
Crystal Structure of BACE with Compound 11monomer09G;EDO;PEG;ZN;60-453
Assess
Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitorsmonomerZN;1BE;60-453
Assess
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly…monomerZN;1BS;60-453
Assess
Crystal Structure of BACE with Compound 9monomer09B;EDO;PEG;ZN;60-453
Assess
Crystal Structure of BACE with Compound 6monomer095;EDO;PEG;ZN;60-453
Assess
Crystal Structure of BACE with Compound 13monomer09E;60-453
Assess
BACE-1 in complex with compound #32monomerQKA;GOL;SO4;54-446
Assess
BACE crystal structure with hydroxy pyrrolidine inhibitormonomerDJV;GOL;54-446
Assess
BACE crystal structure with hydroxy pyrrolidine inhibitormonomerDJS;GOL;54-446
Assess
BACE-1 in complex with compound #17monomerQJV;GOL;SO4;54-446
Assess
BACE crystal structure with hydroxy morpholine inhibitormonomerDK7;GOL;54-446
Assess
Structure of BACE1 bound to SCH626485monomerCS5;55-447
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE INHIBITOR GRL-8234 AND EXOSITE PEPTIDEmonomerBSD;55-447
Assess
Crystal structure of BACE1 with a pyrazole-substituted tetrahydropyran thioamidinemonomerSI5;IOD;GOL;DMS;57-448
Assess
Crystal Structure of BACE1 in complex with N-(3-((4S,5S)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1…monomerIOD;DMS;C7X;57-448
Assess
Crystal structure of BACE-1 in complex with inhibitormonomerCL;012;56-447
Assess
Crystal Structure of BACE1 in complex with (S)-N-(3-(2-amino-6-(fluoromethyl)-4 -methyl-4H-1,3-oxaz…monomerIOD;GOL;0B6;55-446
Assess
APO Structure of BACE1monomerSO4;56-447
Assess
Crystal structure of BACE-1 in complex with inhibitormonomer009;56-447
Assess
BACE-1 in complex with compound #6monomerZQS;56-446
Assess
BACE-1 in complex with compound #34monomerQK7;GOL;56-446
Assess
BACE1 in complex with (R)-N-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-…monomer66F;57-447
Assess
BACE-1 in complex with compound #3monomerQJJ;QJM;GOL;SO4;56-446
Assess
Crystal structure of BACE1 with its inhibitormonomerVTI;SO4;57-447
Assess
APO structure of BACE1monomerSO4;CL;URE;57-447
Assess
Crystal structure of human beta secretase complexed with inhibitormonomer5HA;56-446
Assess
Crystal structure of BACE1 with its inhibitormonomerZPZ;SO4;URE;CL;57-447
Assess
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(isonicotinamido)cyclohexyl)methyl)-…monomer3KU;57-447
Assess
BACE-1 in complex with compound #18monomerZRD;GOL;56-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomer6Z0;NA;DMS;57-447
Assess
Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitorsmonomer1BC;ZN;NA;63-453
Assess
Crystal structure of human Beta-secretase complexed with L-L000430,469monomer3BN;56-446
Assess
Crystal structure of human Beta-secretase complexed with inhibitormonomerI02;56-446
Assess
Crystal structure of Human Bace-1 bound to inhibitormonomerL00;56-446
Assess
Crystal structure of human beta secretase complexed with inhibitormonomerMY9;56-446
Assess
Structure of Beta-Secretase Complexed with Inhibitormonomer56-446
Assess
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in BrainmonomerDMS;1B1;56-446
Assess
BACE1 in complex with (S)-5-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-2,5-dimethyl…monomer66J;57-447
Assess
Structure of BACE-1 in complex with Ligand 13monomerM7D;56-446
Assess
Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37monomer0K9;GOL;56-446
Assess
Crystal Structure of BACE1 in complex with N-(3-((4S,5R)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1…monomerIOD;DMS;C6R;57-447
Assess
Crystal structure of BACE1 with its inhibitormonomerSO4;56-446
Assess
Crystal Structure of Beta-secretase complexed with Inhibitor OM00-3monomer56-446
Assess
Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H…monomerIOD;GOL;66F;56-446
Assess
BACE-1 in complex with ligand 12monomerIOD;GOL;DMS;0EW;57-447
Assess
Crystal structure of human Beta-secretase complexed with inhibitormonomerI03;56-446
Assess
Crystal structure of BACE1 with its inhibitormonomerZPY;SO4;57-447
Assess
Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4…monomerIOD;NA;GOL;C6U;57-447
Assess
BACE-1 complexed with compound 2monomerAEG;57-447
Assess
Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 13monomer1R8;GOL;SO4;57-447
Assess
BACE-1 complexed with compound 4monomerAED;57-447
Assess
BACE-1 complexed with compound 1monomerAEF;57-447
Assess
Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-…monomerIOD;GOL;C7O;57-447
Assess
BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylthio)pyrimidin…monomer954;58-447
Assess
Structure of BACE Bound to 5-(3-(5-chloropyridin-3-yl)phenyl)-5-cyclopropyl-2-imino-3-methylimidazo…monomer0KQ;TLA;58-447
Assess
Structure of BACE Bound to SCH734723monomerTAR;SC7;58-447
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihy…monomerNA;DMS;5T7;GOL;ACT;57-446
Assess
BACE-1 in complex with (4aR,7aS)-7a-(2,6-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-…monomer60T;58-447
Assess
Structure of BACE Bound to SCH736062monomerTAR;BDW;58-447
Assess
Crystal Structure of Human BACE-1 in Complex with amino-1,4-oxazine compound 4monomerD9W;60-449
Assess
BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylamino)pyrimidi…monomerTLA;60S;58-447
Assess
BACE-1 incomplex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoro-4-methoxypyrimidin-2-yl…monomerTLA;60W;58-447
Assess
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(cyclopentylamino)cyclohexyl)methyl)…monomerTLA;3KT;58-447
Assess
Crystal structure of bace1 with novel inhibitormonomerSO4;URE;PEG;58-447
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(cyclohexylamino)-2-hydroxy- 1-(phenylmethyl)propyl)-3-(e…monomerVG7;62-451
Assess
Structure of BACE Bound to 2-fluoro-5-(5-(2-imino-3-methyl-4-oxo-6-phenyloctahydro-1H-pyrrolo[3,4-d…monomerTLA;10W;58-447
Assess
Crystal structure of BACE1 complexed with an inhibitormonomer5HA;CL; 11×URE;SO4;57-446
Assess
BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(4-ethoxy-5-fluoro-6-methylpyrimidin-2-yl)…monomer60U;58-447
Assess
BACE-1 in complex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoropyrimidin-2-yl)-3-methy…monomerTLA;60Y;58-447
Assess
Structure of BACE Bound to SCH722924monomerTAR;CS7;58-447
Assess
BACE crystal structure with tricyclic aminothiazine inhibitormonomer4RY;57-446
Assess
Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(6-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H…monomerTLA;10O;58-447
Assess
Structure of BACE Bound to SCH736201monomerTAR;BDX;58-447
Assess
Crystal structure of BACE1 with its inhibitormonomerZPX;SO4;URE;CL;57-446
Assess
BACE-1 in complex with (4aR,7aS)-7a-(2,4-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-…monomer60X;58-447
Assess
BACE-1 incomplex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)…monomer60V;58-447
Assess
Structure of BACE Bound to SCH727596monomer314;TAR;58-447
Assess
Structure of BACE Bound to 2-imino-5-(3'-methoxy-[1,1'-biphenyl]-3-yl)-3-methyl-5-phenylimidazolidi…monomer0KM;TLA;58-447
Assess
Structure of BACE Bound to SCH709583monomer316;TAR;58-447
Assess
Structure of BACE Bound to SCH723873monomerTAR;BDV;58-447
Assess
Structure of BACE Bound to SCH735310monomerTAR;CS9;58-447
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5S)-2-amino-…monomerNA;DMS;1H6;57-446
Assess
Crystal Structure of BACE with amino thiazine inhibitor LY2886721monomer3YS;GOL;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-…monomerNA;DMS;1HM;57-446
Assess
Crystal Structure of human Beta Secretase complexed with IXSmonomerIXS;57-446
Assess
Structure of BACE Bound to SCH723871monomerTAR;BDQ;58-447
Assess
Structure of BACE Bound to SCH713601monomerTAR;BDO;58-447
Assess
Structure of BACE bound to SCH743813monomer74A;TLA;57-446
Assess
Structure of BACE Bound to SCH726222monomer318;TAR;58-447
Assess
Structure of BACE Bound to 2-imino-3-methyl-5,5-diphenylimidazolidin-4-onemonomer0KK;TLA;58-447
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-di…monomerNA;DMS;1HQ;57-446
Assess
Structure of BACE Bound to (S)-3-(5-(2-imino-1,4-dimethyl-6-oxohexahydropyrimidin-4-yl)thiophen-3-y…monomerTLA;13W;58-447
Assess
BACE1 in complex with 4-(3-(furan-2-carboxamido)phenyl)-1-methyl-5-oxo-4-phenylimidazolidin-2-imini…monomerTLA;66H;58-447
Assess
Structure of BACE Bound to 2-((7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-2-imino-3-methyl-4-oxohexah…monomerTLA;10Q;58-447
Assess
Structure of BACE Bound to (R)-5-cyclopropyl-2-imino-3-methyl-5-(3-(5-(prop-1-yn-1-yl)pyridin-3-yl)…monomer0KR;TLA;58-447
Assess
Structure of BACE Bound to SCH745966monomerSC6;TAR;58-447
Assess
A multiconformer ligand model of 5T5 bound to BACE-1monomerNA;DMS;5T5;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH {(1R,2R)-2-[(R)-2-Amino-4-(4-difluoromethoxy-phenyl)-4,…monomer5T5;NA;DMS;57-446
Assess
Structure of BACE Bound to 2-imino-3-methyl-5-phenyl-5-(3-(pyridin-3-yl)phenyl)imidazolidin-4-onemonomer0KP;TLA;58-447
Assess
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((R)-1-(2-cyclopentylacetyl)pyrrolidin-3-yl)met…monomer3KO;58-447
Assess
BACE crystal structure with bicyclic aminothiazine inhibitormonomer4RZ;GOL;57-446
Assess
Structure of Bace-1 in complex with Ligand 8monomerHRV;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R)-2-amino-…monomerNA;DMS;1H7;57-446
Assess
BACE-1 in complex with compound #22monomerZR7;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-[3-[(3-chloro-8-quinolyl)amino]phenyl]-5-methyl-2,6-d…monomerNA;DMS;5T8;57-446
Assess
Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H…monomerTLA;10V;58-447
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-me…monomerNA;DMS;1H8;57-446
Assess
BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidi…monomerTLA;3KW;58-447
Assess
Structure of BACE Bound to SCH710413monomerTAR;BDJ;58-447
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-…monomerNA;DMS;1HO;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5…monomerNA;DMS;6T9;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6R)-2-ami…monomerNA;DMS;1HH;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomerWZV;NA;DMS;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (4S)-4-[3-(5-chloro-3-pyridyl)phenyl]-4-[4-(difluoromet…monomer5T6;DMS;NA;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-…monomerNA;DMS;1H5;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-ami…monomerNA;DMS;1HG;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-…monomerNA;DMS;1HJ;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-…monomerNA;DMS;1HL;57-446
Assess
Structure of bace (beta secretase) in Complex with EV0monomerEV0;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomer8T3;NA;DMS;57-446
Assess
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-p…monomerF1I;57-446
Assess
Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4- fluo…monomerIOD;GOL;H3C;57-446
Assess
Crystal Structure of BACE1 in complex with N-{3-[(3S)-1-amino-5-fluoro-3-methyl-3,4-dihydro-2,6-nap…monomerIOD;GOL;GUC;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGANDmonomerXK0;NA;DMS;57-446
Assess
Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihyd…monomerIOD;GOL;DMS;C83;57-446
Assess
human Bace (beta secretase) in complex with Cyclohexanecarboxylic acid (2-(2-am ino-6-phenoxy-4H-qu…monomerQUD;60-449
Assess
Crystal structure of BACE1 in complex with OM99-2 at pH 5.0monomer57-446
Assess
BACE-1 IN COMPLEX WITH LIGAND 32397778monomerIII;CL;57-446
Assess
CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH Pep#3monomerCL;58-447
Assess
Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazin…monomerF1K;57-446
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326monomer0GO;59-447
Assess
Crystal Structure of Human Beta Secretase Complexed with inhibitormonomerSO4;35A;58-446
Assess
BACE1 in complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspi…monomer4QA;58-446
Assess
Structure of BACE in complex with (S)-4-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-…monomer0V6;58-446
Assess
Crystal Structure of Hydroxyethyl Secondary Amine-based Peptidomimetic Inhibitor of Human Beta-Secr…monomerF2I;59-447
Assess
BACE-1 in complex with compound #18monomerQJP;GOL;SO4;58-446
Assess
BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4-(((1S,3R)-3-(3-phenylureido)cyclo…monomerTLA;779;58-446
Assess
Crystal structure of bace1 with its inhibitormonomerSO4;0U4;URE;58-446
Assess
Crystal structure of Bace1 with its inhibitormonomerSO4;58-446
Assess
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functiona…monomerP6U;IOD;EDO;58-446
Assess
BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571monomer0XA;ACT;GOL;58-446
Assess
Structure of bace (beta secretase) in complex with inhibitormonomerEV3;GOL;58-446
Assess
Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatme…monomerACT;NA;32D;57-445
Assess
Bace1 with the aminohydantoin Compound R-58monomer569;59-447
Assess
BACE1 in complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-…monomer4QD;58-446
Assess
Crystal structure of human Beta secretase complexed with inhibitormonomer32P;58-446
Assess
Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relatio…monomer1LI;59-447
Assess
Crystal structure of BACE with amino thiazine inhibitor LY2811376monomer4B2;GOL;58-446
Assess
Crystal structure of BACE1 in complex with aminoquinoline inhibitor 6monomer68J;GOL;60-448
Assess
Bace1 with the aminohydantoin Compound 37monomerX45;59-447
Assess
Crystal structure of beta-secretase bound to a potent and highly selective inhibitor.monomerZPQ;58-446
Assess
New substrate binding pockets for beta-secretase.monomer58-446
Assess
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3…monomerF1M;58-446
Assess
Structure of BACE-1 Bound to (7aR)-6-benzoyl-7a-(4-(3-cyanophenyl)thiophen-2-yl)-3-methyl-4-oxohexa…monomer10J;58-446
Assess
Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Desi…monomer508;SO4;GOL;58-446
Assess
Crystal Structure of Human BACE-1 in Complex with Compound NB-360 (compound 54)monomerSLK;59-447
Assess
BACE crystal structure with bicyclic aminothiazine fragmentmonomer4RW;GOL;58-446
Assess
BACE crystal structure with hydroxy pyrrolidine inhibitormonomerDKJ;GOL;58-446
Assess
Crystal Structure of Unbound Beta-Secretase Catalytic Domain.monomer58-446
Assess
Crystal Structure of Human Beta Secretase Complexed with inhibitormonomerSO4;712;58-446
Assess
BACE1 in complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.…monomer4QF;58-446
Assess
Crystal structure of Beta-secretase bound to a long inhibitor with additional upstream residues.monomer58-446
Assess
Crystal structure of GRL-8234 bound to BACE (Beta-secretase)monomerBSD;58-446
Assess
Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl…monomerIOD;GOL;B00;58-446
Assess
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-b…monomerF1L;58-446
Assess
Crystal structure of BACE1 bound to inhibitormonomerSO4;GOL;5MS;58-446
Assess
Crystal structure of human BACE-1 bound to Compound 36monomer3VP;IOD;DMS;58-446
Assess
Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cy…monomerIOD;GOL;0B1;58-446
Assess
Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitor (2)monomerLIQ;59-447
Assess
Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-d…monomerIOD;GOL;C86;58-446
Assess
Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relatio…monomerSO4;GOL;2LI;59-447
Assess
Structure of BACE1 in complex with N-(3-((4R,5R,6S)-2-amino-6-(1,1-difluoroethyl)-5-fluoro-4-methyl…monomerIOD;GOL;DMS;0B5;58-446
Assess
Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazin…monomerF1J;58-446
Assess
Crystal Structure of BACE1 in complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa…monomerIOD;GOL;GX6;58-446
Assess
Bace1 with the aminohydantoin Compound 29monomer593;59-447
Assess
Crystal structure of human beta secretase complexed with NVP-AMK640monomer58-446
Assess
Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing i…monomerC6A;58-446
Assess
BACE crystal structure with tricyclic aminothiazine inhibitormonomer4RX;58-446
Assess
Crystal Structure of BACE1 in complex with N-{3-[(4R)-2-amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4H-1,3…monomerIOD;GOL;GTU;58-446
Assess
Structure of Bace (beta secretase) in complex with ligand EV2monomerEV2;58-446
Assess
Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3monomer23I;58-446
Assess
CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,…monomer7H3;58-446
Assess
Crystal structure of human BACE-1 bound to Compound 6monomer3WP;IOD;NA;GOL;DMS;58-446
Assess
Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4…monomerF1H;58-446
Assess
Crystal structure of BACE1 with its inhibitormonomerVSI;58-446
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151monomer0GU;IOD;58-446
Assess
BACE-1 in complex with ELN380842monomer842;59-447
Assess
Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3…monomerF1N;58-446
Assess
Crystal Structure of a cycloamide-urethane-derived novel inhibitor bound to human brain memapsin 2 …monomerMMI;58-446
Assess
Structure of BACE1 complex with a syn-HEA-type inhibitormonomer59-447
Assess
X-ray structure of BACE1 in complex with a bicyclic isoxazoline carboxamide as the P3 ligandmonomerGHJ;GOL;URE;58-446
Assess
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functiona…monomer74B;IOD;NA;GOL;DMS;CL;58-446
Assess
Crystal structure of BACE1 with its inhibitormonomer59-447
Assess
Crystal Structure of Human BACE-1 in Complex with CNP520monomerBUH;59-446
Assess
Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse…monomer1W0;DMS;60-447
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BQQ711monomer0GS;59-446
Assess
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brainmonomer2FB;58-445
Assess
Crystal structure of BACE1 in complex with aminoquinoline compound 1monomerIOD;68M;GOL;60-447
Assess
BACE1 IN COMPLEX WITH compound 3 (NB-641)monomerSKW;59-446
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a soaking experi…monomerBXD;59-446
Assess
Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse…monomer1W2;ACT;60-447
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BXQ490monomerBXQ;59-446
Assess
Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMP…monomerACT;QN7;58-445
Assess
Apo Structure of BACE (Beta Secretase)monomerIOD;60-447
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a soaking experi…monomer0GT;59-446
Assess
Crystal Structure of Human BACE-1 in Complex with Compound 38a (NB-854)monomerSL8;60-447
Assess
Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49monomerIOD;3LO;GOL;60-447
Assess
Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COM…monomerACT;NA;7F3;58-445
Assess
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in BrainmonomerDMS;54M;58-445
Assess
Crystal structure of human Beta Secretase complexed with I21monomerI21;59-446
Assess
Crystal structure of BACE1 with its inhibitormonomer60-447
Assess
Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COM…monomerACT;I6X;58-445
Assess
Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse…monomer1W1;ACT;DMS;60-447
Assess
co-crystal structure of BACE with inhibitor AM-6494monomerIOD;GOL;P6J;60-447
Assess
Crystal structure of BACE1 in complex with (Z)-fluoro-olefin containing compound 15monomerU64;IOD;60-447
Assess
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brainmonomer6T6;58-445
Assess
New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in BrainmonomerACT;6TG;58-445
Assess
Structure of Bace-1 (Beta-Secretase) in complex with : N-(3-((1R,5S,6R)-3-amino-5-methyl-2-oxa-4-az…monomerIOD;GOL;SO4;EJ7;60-447
Assess
Crystal Structure of Human Beta Secretase in Complex with Compound 11amonomer1YS;59-446
Assess
Crystal structure of BACE complex with BMC022monomerE51;59-446
Assess
Crystal structure of human beta-secretase in complex with NVP-AFJ144monomerAFJ;59-446
Assess
Crystal structure of BACE complex with BMC025monomerAFJ;59-446
Assess
Bace1 with the aminohydantoin Compound S-34monomerX17;59-446
Assess
Human bace-1 complex with bjc060monomerBJC;59-446
Assess
Fragment Based Discovery and Optimisation of BACE-1 InhibitorsmonomerIOD;GOL;EV4;60-447
Assess
Crystal structure of BACE complex with BMC020 hydrolyzedmonomerGOL;E7A;59-446
Assess
Crystal structure of human beta secretase complexed with NVP-AUR200monomer59-446
Assess
Crystal Structure of Human Beta Secretase in Complex with compound 11dmonomer1YT;59-446
Assess
Crystal structure of BACE complex with BMC001monomerE4Y;59-446
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystalliza…monomerBXD;59-446
Assess
Bace1 in complex with the aminohydantoin Compound 4gmonomerZ81;59-446
Assess
Crystal structure of human beta-secretase in complex with NVP-BAV544monomerBAV;59-446
Assess
Potent Beta-Secretase 1 hydroxyethylene InhibitormonomerMV7;59-446
Assess
Crystal structure of human beta-secretase in complex with NVP-ARV999monomerAR9;59-446
Assess
Crystal structure of BACE complex with BMC002monomerBAV;59-446
Assess
Crystal structure of BACE complex with BMC013monomerE74;59-446
Assess
Crystal structure of BACE complex with BMC021monomerAR9;59-446
Assess
Crystal structure of BACE complex with BMC019 hydrolyzedmonomerGOL;E77;59-446
Assess
Crystal Structure of the Bace complex with AXQ093, a macrocyclic inhibitormonomerAXQ;59-446
Assess
Crystal structure of BACE complex with BMC023monomerAXQ;59-446
Assess
Human BACE-1 complex with NB-216monomer0BI;59-446
Assess
Crystal structure of BACE complex with BMC014monomer0BI;59-446
Assess
BACE1 in complex with a macrocyclic inhibitormonomerL3M;SO4;59-446
Assess
BACE1 in complex with a macrocyclic inhibitormonomerL3J;59-446
Assess
Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene inhibitor 2monomerIOD;GOL;SO4;68L;60-447
Assess
Crystal structure of BACE complex with BMC008monomerE5P;59-446
Assess
Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitorsmonomer18P;SO4;59-446
Assess
SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors.monomer1BL;59-446
Assess
Crystal structure of beta-secretase 1 in complex with selective beta-secretase 1 inhibitormonomer586;SO4;59-446
Assess
BACE-1 in complex with ELN475957monomer957;59-446
Assess
SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitorsmonomer957;59-446
Assess
Crystal structure of BACE complex with BMC026monomerE4J;SO4;59-446
Assess
Crystal structure of BACE complex with BMC007monomerE5D;59-446
Assess
Bace-1 with Compound 3monomer454;59-446
Assess
Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitorsmonomerQBH;59-446
Assess
Human BACE-1 COMPLEX WITH AYH011monomerAYH;59-446
Assess
Crystal structure of BACE complex with BMC023monomerE5A;59-446
Assess
Bace-1 inhibitor complexmonomer1QU;59-446
Assess
Crystal structure of BACE1 in complex with biarylspiro aminooxazoline 6monomerIOD;DWA;DMS;60-447
Assess
Crystal Structure of the Bace complex with BDF488, a macrocyclic inhibitormonomerAXF;59-446
Assess
Crystal Structure of Human Beta Secretase in Complex with compound 12amonomer1YU;59-446
Assess
Crystal structure of BACE complex with BMC009monomerE6P;59-446
Assess
Crystal structure of BACE complex with BMC015monomerE5V;59-446
Assess
Crystal structure of BACE complex with BMC024monomerAXF;59-446
Assess
Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivit…monomer1QT;59-446
Assess
Structure of BACE complexed to compound 1monomerXX4;59-446
Assess
Crystal Structure of Human Beta Secretase in Complex with BFG356monomer3P5;59-446
Assess
Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a co-crystalliza…monomer0GT;59-446
Assess
Crystal structure of BACE complex with BMC011monomerE61;59-446
Assess
Crystal structure of BACE complex with BMC003monomerE6V;59-446
Assess
Crystal structure of BACE complex with BMC018monomerE4G;59-446
Assess
Crystal structure of BACE complex with BMC010monomerE6M;59-446
Assess
Co-crystal of BACE1 with compound 0211monomer5E7;59-446
Assess
BACE-1 complexed with compound 3monomerAEH;60-447
Assess
Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitormonomerPO4;LIJ;59-446
Assess
Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1monomerPO4;MR0;59-446
Assess
Crystal structure of beta-secretase complexed with an amino-ethylene inhibitormonomerFRP;59-446
Assess
Potent beta-secretase 1 inhibitormonomer929;59-446
Assess
Crystal structure of BACE complex with BMC017monomerE6J;59-446
Assess
Crystal structure of BACE complex with BMC004monomerE6S;59-446
Assess
Crystal structure of BACE1 complexed with an inhibitormonomer5HA;CL;60-447
Assess
BACE (Beta Secretase) in complex with a nanomolar non-peptidic inhibitormonomerIOD;L01;60-447
Assess
Beta-secretase 1 complexed with statine-based inhibitormonomer757;IPA;59-446
Assess
Fragment based discovery and optimisation of bace-1 inhibitorsmonomerEV6;IOD;60-447
Assess
Crystal structure of BACE complex with BMC005monomerE6Y;59-446
Assess
Discovery of aminoheterocycles as a novel beta-secretase inhibitor classmonomerB35;59-446
Assess
Crystal structure of BACE complex with BMC016monomerE4A;59-446
Assess
Crystal Structure of BACE-1 in complex with AHM178monomerXLI;59-446
Assess
Structure of BACE1 complex with 2-thiophenyl HEA-type inhibitormonomer60-447
Assess
Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28monomerIOD;43K;GOL;60-446
Assess
BACE-1 in complex with a HEA-macrocyclic type inhibitormonomer0LG;60-446
Assess
Crystal structure of BACE1 at pH 7.0monomer60-446
Assess
Crystal structure of BACE1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22monomerIOD;GOL;3UT;60-446
Assess
BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512monomer0N1;60-446
Assess
Crystal structure of BACE1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitormonomer3LL;IOD;GOL;60-446
Assess
Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene compound 12monomerIOD;8QV;GOL;60-446
Assess
Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19monomerIOD;1R6;GOL;60-446
Assess
BACE1 compound 23monomerB7T;62-448
Assess
Crystal structure of BACE1 in complex with aminooxazoline xanthene 9lmonomerIOD;DWB;GOL;DMS;60-446
Assess
(4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amin…monomer6WD;60-446
Assess
Compound 10monomerGOL;IOD;5QU;60-446
Assess
Bace1 with Compound 30monomer472;59-445
Assess
X-ray structure of Bace-1 in complex with compound 3.b.10monomer310;59-445
Assess
Structure of beta-secretase complexed with inhibitormonomer0GH;LPD;60-446
Assess
Crystal structure of BACE1 in complex with aminooxazoline xanthene 11amonomerIOD;DWD;GOL;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 4monomerIOD;DMS;7IP;GOL;60-446
Assess
Compound 18monomerGOL;IOD;5QV;60-446
Assess
(4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,…monomerIOD;6WE;60-446
Assess
X-ray crystal structure of beta secretase complexed with 4-(4-fluorobenzyl)piperidinemonomerIOD;DMS;4FP;60-446
Assess
Crystal structure of BACE1 in complex with aminoquinoline inhibitor 9monomer68K;60-446
Assess
BACE1 in complex with inhibitor 5gmonomerSO4;8W4;URE;60-446
Assess
Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitorsmonomer591;59-445
Assess
Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitorsmonomer532;59-445
Assess
X-ray crystal structure of beta secretase complexed with 1-amino-isoquinolinemonomerIOD;DMS;1SQ;60-446
Assess
Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-t…monomerGOL;IOD;0B3;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 5monomerIOD;DMS;CMZ;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 6amonomerIOD;DMS;8IP;GOL;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 3monomerIOD;DMS;6IP;60-446
Assess
Crystal structure of BACE1 in complex with 3-(2-amino-6-(o-tolyl)quinolin-3-yl)-N-(3,3-dimethylbuty…monomerIOD;GOL;6BS;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 7monomerIOD;DMS;IP6;60-446
Assess
Bace1 with Compound 38monomerBX2;59-445
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)p…monomerIOD;GOL;3RU;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 8bmonomerIOD;DMS;IP7;60-446
Assess
Crystal structure of BACE1 at pH 4.5monomer60-446
Assess
BACE1 in complex with a macrocyclic inhibitormonomerL4J;SO4;59-445
Assess
Bace-1 with the aminopyridine Compound 32monomer625;59-445
Assess
Fragment Based Discovery and Optimisation of BACE-1 InhibitorsmonomerIOD;EV5;60-446
Assess
Crystal structure of BACE1 at pH 5.0monomer60-446
Assess
Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2monomer3LN;IOD;60-446
Assess
X-ray crystal structure of beta secretase complexed with compound 6bmonomerIOD;DMS;9IP;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with 6-(Thiophen-3-yl)quinolin-2-aminemonomerIOD;RSV;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-…monomerIOD;GOL;3RS;60-446
Assess
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-DB-MUT) complex with N-(N-(4- acetamido-…monomer0VB;IOD;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'…monomerIOD;GOL;0MP;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3…monomerIOD;GOL;0KN;60-446
Assess
Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl…monomerGOL;B02;60-446
Assess
Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyc…monomerIOD;GOL;DMS;0B4;60-446
Assess
Bace-1 in complex with a norstatine type inhibitormonomer038;59-445
Assess
Crystal structure of BACE complex withBMC006monomerE5Y;59-445
Assess
1,4-Oxazine BACE1 inhibitorsmonomer52K;IOD;CL;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(…monomerIOD;GOL;RVI;60-446
Assess
crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with N-(N-(4-amino-3,5- dich…monomer0VA;IOD;60-446
Assess
X-ray crystal structure of beta secretase complexed with 2-aminoquinolinemonomerIOD;DMS;2AQ;60-446
Assess
X-ray crystal structure of beta secretase complexed with N~3~-benzylpyridine-2,3-diaminemonomerIOD;DMS;8AP;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with 6-(2-(3,3-Dimethylbut-1-ynyl)phenyl)quinolin-2…monomerIOD;RTH;60-446
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexy…monomerIOD;GOL;RTN;60-446
Assess
Crystal structure of BACE1 at pH 4.0monomer60-446
Assess
Structure of BACE1 complex with a HEA-type inhibitormonomer60-446
Assess
Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-cyclohexyl-N-methyl…monomerIOD;GOL;RTM;60-446
Assess
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3S)-3-(acetyla…monomerPB7;IOD;60-446
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomerVG4;62-447
Assess
Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)…monomerZY0;62-447
Assess
Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-…monomerZY1;62-447
Assess
Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2…monomerC44;62-447
Assess
Human BACE-1 in complex with 3-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoro…monomerVG6;62-447
Assess
Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-…monomerZYE;62-447
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomerXFI;62-447
Assess
Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2…monomerCM8;62-447
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomerAA9;62-447
Assess
Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitorsmonomer916;61-446
Assess
Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran…monomerZY4;62-447
Assess
Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitorsmonomer996;61-446
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomerVG5;62-447
Assess
Bace1 in complex with the aminohydantoin Compound 102monomerZOO;60-445
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomerVG5;62-447
Assess
Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-…monomerZY2;62-447
Assess
Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-…monomerVG3;62-447
Assess
Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)…monomerCM7;62-447
Assess
Human BACE-1 in complex with N-((1S,2R)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-…monomerVG0;62-447
Assess
Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMP…monomerACT;S8Z;60-445
Assess
Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)am…monomerZY3;GOL;62-447
Assess
Bace1 in complex with the aminopyridine Compound 44monomer879;59-444
Assess
X-ray structure of Bace-1 in complex with compound 6gmonomer411;60-445
Assess
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with BMS-693391 AKA (2S)-2-(…monomerPB0;60-445
Assess
BACE1 with Compound 1monomer251;59-444
Assess
Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamid…monomerPB8;60-445
Assess
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in BrainmonomerWM9;61-445
Assess
BACE1 with Compound 2monomer462;60-444
Assess
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in BrainmonomerKGG;62-445
Assess
Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding ScaffoldmonomerGMF;ACT;62-445
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerB7E;0.856ej2.1.A37-445
99.60
Assess

5 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomerB7E;0.826ej2.1.A37-420
97.22
Assess
Isoform 3monomer0.796ej2.1.A37-401
99.56
Assess
Isoform 4monomer0.806ej2.1.A37-376
96.50
Assess
Isoform 5monomer0.866ej2.1.A2-345
96.00
Assess
Isoform 6monomer0.846ej3.1.A2-323
93.33
Assess

Alignments